← Back to Search

Behavioral Intervention

Health Communication Tool + SDoH Screening for Lung Cancer

N/A

Recruiting

Led By Lisa Carter-Bawa, PhD

Research Sponsored by Hackensack Meridian Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged 50 years to 80 years

20 pack-year smoking history

Must not have

Diagnosed with lung cancer

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months post intervention

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to increase lung cancer screening rates, understanding of effective screening strategies, and reduce lung cancer burden through a tailored health communication & decision support tool combined with social determinants of health (SDoH) screening.

Who is the study for?

This trial is for individuals aged 50-80 who can consent, currently smoke or quit within the last 15 years, have a history of significant smoking (20 pack-years), and have never had lung cancer screening. They must speak and understand English. Those with previous lung screenings or diagnosed with lung cancer are excluded.

What is being tested?

The study tests if adding a Social Determinants of Health (SDoH) assessment and referral process to a community-based educational tool improves lung cancer screening rates compared to just the educational tool alone in at-risk communities.

What are the potential side effects?

Since this trial focuses on education and social assessments rather than medical treatments, there are no direct side effects like those seen with drugs or surgeries. However, participants may experience stress or anxiety related to learning about their health risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 50 and 80 years old.

Select...

I have smoked the equivalent of a pack a day for 20 years.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have been diagnosed with lung cancer.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months post intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months post intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months post intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Lung cancer screening uptake

Secondary study objectives

Health Literacy

Knowledge of Lung Cancer and Lung Screening

Lung Cancer Fatalism

+4 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Social determinants of health screeningExperimental Treatment2 Interventions

Participants will receive a social determinants of health screening assessment and referral process in addition to the community-based lung cancer screening educational tool.

Group II: Community-based lung cancer screeningActive Control1 Intervention

Participants will receive a community-based lung cancer screening educational tool.

0 / 3Eligibility criteria met